Physician profile
Joseph Schuld
NPI 1144800624
$706.79
in general payments reported to CMS, 2019-2025
13 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.45 · 2022: $16.36 · 2023: $81.76 · 2024: $380 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $205.36 | 2023-2025 | Verquvo |
| Inari Medical, INC. | $155.68 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Wainua |
| Novartis Pharmaceuticals Corporation | $36.20 | 2024 | |
| Amgen INC. | $31.38 | 2024 | Repatha |
| Bard Peripheral Vascular, INC. | $26.67 | 2021 | |
| Philips North America LLC | $25.51 | 2025 | Extended Holter |
| Alnylam Pharmaceuticals INC. | $18.67 | 2025 | Onpattro |
| Tactile Systems Technology INC | $17.42 | 2023 | Flexitouch Plus, Entre Plus |
| Kiniksa Pharmaceuticals, LTD. | $17.00 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $16.76 | 2023 | Camzyos |
| Boston Scientific Corporation | $16.36 | 2022 | |
| Glaxosmithkline, LLC. | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Schuld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.